发明名称 |
Human arginase and pegylated human arginase and the use thereof |
摘要 |
The present invention provides a site-directed mutated arginase and the preparation method thereof, and the use of said site-directed mutated arginase in preparing a medicament for treating an arginase-related disease. The present invention also provides a pegylated arginase and the preparation method thereof, and the use of said pegylated arginase in preparing a medicament for treating an arginase-related disease. |
申请公布号 |
US9109218(B2) |
申请公布日期 |
2015.08.18 |
申请号 |
US201214368507 |
申请日期 |
2012.12.23 |
申请人 |
Bio-Cancer Treatment International Ltd. (Shanghai) |
发明人 |
Cheng Ning Man;Chen Li |
分类号 |
C12N9/78;A61K38/50;C12N9/96 |
主分类号 |
C12N9/78 |
代理机构 |
Eagle IP Limited |
代理人 |
Eagle IP Limited ;Lui Jacqueline C. |
主权项 |
1. An arginase, wherein said arginase is human arginase I comprising an amino acid sequence of SEQ ID NO:1 comprising a mutation at position 45 of said SEQ ID NO:1; wherein said mutation is from cysteine to alanine;
wherein said arginase has activity. |
地址 |
Shanghai CN |